Impact of a New Reimbursement Program on Hepatitis B Antiviral Medication Cost and Utilization in Beijing, China

BACKGROUND: Hepatitis B virus (HBV) infection is a significant clinical and financial burden for chronic hepatitis B (CHB) patients. In Beijing, China, partial reimbursement on antiviral agents was first implemented for the treatment of CHB patients in July 1, 2011. AIMS: In this study, we describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Qian, Li, Yan, Duan, Xiao-wan, Yang, Li-kun, Chen, Yu, Li, Hui, Wang, Li, Duan, Zhong-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199609/
https://www.ncbi.nlm.nih.gov/pubmed/25329072
http://dx.doi.org/10.1371/journal.pone.0109652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199609/
https://www.ncbi.nlm.nih.gov/pubmed/25329072
http://dx.doi.org/10.1371/journal.pone.0109652

Ejemplares similares